Orionis Biosciences, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2015-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.orionisbio.com
Clinical Trials
2
Active:1
Completed:0
Trial Phases
1 Phases
Phase 1:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 1
2 (100.0%)ORB-021 in Patients with Advanced Solid Tumors
- First Posted Date
- 2024-09-23
- Last Posted Date
- 2025-01-06
- Lead Sponsor
- Orionis Biosciences Inc
- Target Recruit Count
- 36
- Registration Number
- NCT06607939
- Locations
- 🇺🇸
Honor Health Clinical Research, Scottsdale, Arizona, United States
🇺🇸MDAC, Houston, Texas, United States
ORB-011 In Patients With Advanced Solid Tumors
- First Posted Date
- 2023-07-17
- Last Posted Date
- 2025-04-23
- Lead Sponsor
- Orionis Biosciences Inc
- Target Recruit Count
- 55
- Registration Number
- NCT05947474
- Locations
- 🇺🇸
Honor Health Research Institute, Scottsdale, Arizona, United States
🇺🇸MD Anderson Center, Houston, Texas, United States
News
No news found